Clinical Trials Logo

Neuralgia clinical trials

View clinical trials related to Neuralgia.

Filter by:

NCT ID: NCT03973983 Completed - Neuralgia Clinical Trials

Comparison of Ultrasound-guided Transgluteal and Finger-guided Transvaginal Pudendal Nerve Block Techniques

Start date: November 1, 2016
Phase: N/A
Study type: Interventional

Pudendal neuralgia (PN) is a painful and disabling condition, which reduces the quality of life as well. Pudendal nerve injections are essential for the diagnosis and the management of PN. The purpose of this study was to compare the effectiveness of finger-guided transvaginal pudendal nerve injection (TV-PNI) technique and the US-guided transgluteal pudendal nerve injection (TG-PNI) technique.

NCT ID: NCT03965884 Completed - Clinical trials for Peripheral Neuropathy

Clinical Effects of Lumbal Stabilization Exercises and Connective Tissue Massage on Neuropathic Pain, Functional Capacity and Quality of Life

Start date: April 18, 2018
Phase: N/A
Study type: Interventional

The aim of the study is to investigate the efficacy of connective tissue massage and lumbar stabilization exercise treatment on pain severity, functional capacity and quality of life in those who have experienced peripheral neuropathy

NCT ID: NCT03940963 Completed - Morton's Neuroma Clinical Trials

Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain

REPOSE
Start date: October 10, 2018
Phase: N/A
Study type: Interventional

Comparing safety, pain, user experience, healthcare economic costs, work productivity, impairment and quality of life outcomes between Axoguard® Nerve Cap and neurectomy in the treatment of symptomatic neuromas in the foot. Study consists of a 15 subject pilot phase with Axoguard® Nerve Cap implants followed for 3 months and then a comparative study of 86 subjects randomized between the treatment groups followed for 12 months.

NCT ID: NCT03928093 Completed - Pain, Neuropathic Clinical Trials

Pregabalin Treatment for RDEB Pain and Itch

Start date: August 7, 2019
Phase: Phase 3
Study type: Interventional

Recessive dystrophic epidermolysis bullosa (RDEB) patients' quality of life is severely affected by neuropathic pain and itch, which have recently been demonstrated to be secondary to skin small fiber neuropathy. To date, there is no evidence on what the best agent is to control these symptoms. Based on the anecdotal data and safety profile, the investigators believe that pregabalin is a therapeutic agent that will be effective and safe in this population. The investigators propose to conduct a blinded study, using pregabalin versus placebo in which each patient serves as its own control (cross-over design). This is a feasibility study that will provide preliminary data on efficacy and safety of pregabalin in RDEB patients with neuropathic pain and itch and gather much needed data (dosage, titration schedule, outcome measures, etc) to inform the design of a larger cohort, controlled, multicenter trial.

NCT ID: NCT03926364 Completed - Neuropathic Pain Clinical Trials

Profile of Pain and Unpleasant Sensations in Patients With Referred Pain

Start date: March 30, 2018
Phase:
Study type: Observational

This feasibility study primarily aimed to assess the technology acceptance and usability of a pain tracking software in patients with spinally referred chronic pain. The secondary aim was to assess the fluctuations in pain intensity and distribution, using the pain tracking software during a 3-month period. Additionally, the study aimed to explore the patients' behavior when self-reporting pain when given the opportunity to use a variety of pain quality descriptors, such as tingling, burning and stabbing. Patients with spinally referred chronic pain will be recruited to participate. Participants will be asked to use a pain tracking software to create weekly pain reports for a 3-month period. These pain reports consist of pain drawings and intensity scales. Additionally, patients will complete baseline disability and pain catastrophizing online questionnaires. The project does not affect treatment or does not offer any intervention.

NCT ID: NCT03909841 Completed - Diabetes Mellitus Clinical Trials

Neuropathic Pain in Elderly People With Diabetes: Impact on Quality of Life and Cognition

Start date: June 1, 2017
Phase:
Study type: Observational

This study was set out 1) Evaluate the impact of Diabetic Peripheral Neuropathy (DPN) and DPN-P (Diabetic Peripheral Neuropathic Pain) on the overall Quality of Life (QoL) in elderly with Diabetic Mellitus (DM) and 2) Evaluate the association between cognition impairments and DM in the elderly, and the contributions of DPN and/or DPN-P

NCT ID: NCT03901352 Completed - Clinical trials for Central Neuropathic Pain

Study of Mirogabalin for Central Neuropathic Pain

Start date: March 12, 2019
Phase: Phase 3
Study type: Interventional

Investigate the efficacy and safety of mirogabalin in participants with central neuropathic pain in comparison to placebo

NCT ID: NCT03899246 Completed - Sickle Cell Disease Clinical Trials

Sickle Cell Pain: Intervention With Capsaicin Exposure

SPICE
Start date: July 3, 2019
Phase: Phase 1
Study type: Interventional

This study evaluates the safety and feasibility of using high dose topical capsaicin patches for the treatment of neuropathic pain in pediatric patients with sickle cell disease, as well as the feasibility of using a number of tests for the evaluation and monitoring of neuropathic pain. The hypothesis, based on evidence obtained from studies in adults with neuropathic pain related to other diseases as well as a single previously published study of capsaicin in pediatric patients, is that capsaicin will be well tolerated in this population. Additionally, it is hypothesized that it is feasible to monitor changes in neuropathic pain via the testing listed below.

NCT ID: NCT03890315 Completed - Neuropathic Pain Clinical Trials

Evaluation of Neuropathic Pain in the Context of Clinical Symptoms, Quantitative Sensory Tests and Imaging With FMRI

Start date: April 26, 2019
Phase:
Study type: Observational

This study is planned to evaluate patients with upper extremity neuropathic pain due to cervical radiculopathy with clinical symptoms, Quantitative Sensory Testing(QST) and Functional Magnetic Resonance Imaging(fMRI). Patients with similar charactheristics will be grouped and comparisons will be conducted in fMRI results, as well as QST.

NCT ID: NCT03889353 Completed - Neuropathic Pain Clinical Trials

Brain Computer Interface and Virtual Reality (BCI-VR) for Pain Treatment

GHOST
Start date: May 9, 2019
Phase: N/A
Study type: Interventional

Pilot Interventional study with minimal risks and constraints, prospective, monocentric. Safety and Efficacity evaluation of a Novel Medical Device.